The information highlighted (if any) are the most recent updates for this brand.
This drug is contraindicated: In patients with hypersensitivity to Rosuvastatin or any ingredients in the formulation; in patients with active liver disease, including unexplained, persistent elevations in hepatic aminotransferase (transaminase) concentrations; in women who are or may become pregnant; in nursing women; in patients with severe renal impairment (creatinine clearance < 30 ml/min/1.73 m2); in patients with myopathy; in patients receiving concomitant cyclosporin.